AMGEN - BIOFARMACEUTICA, LDA. secures contract for Adalimumab Biosimilar 40Mg 0 4Ml Sol Inj Pen 04 Ml Sc

Portugal, April 7 -- Portugal based AMGEN - BIOFARMACEUTICA, LDA. has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Adalimumab Biosimilar 40Mg 0 4Ml Sol Inj Pen 04 Ml Sc. The value of the contract is worth 37787600 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....